PPT-Gender differences in pre-clinical models of Chemotherapy Induced Neuropathy
Author : naomi | Published Date : 2023-11-22
Daniel W Cohn September 2022 From preclinical to clinical Lack of robust nonevoked pain endpoints Lack of translatable Biomarkers Lack of studies taking gender differences
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Gender differences in pre-clinical model..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Gender differences in pre-clinical models of Chemotherapy Induced Neuropathy: Transcript
Daniel W Cohn September 2022 From preclinical to clinical Lack of robust nonevoked pain endpoints Lack of translatable Biomarkers Lack of studies taking gender differences into account In vivo preclinical. Sensory Neuropathy . Sandra E. Kurtin, RN, MS, AOCN. ®. , ANP-C. Clinical Assistant Professor of Medicine. Adjunct Clinical Assistant Professor of Nursing. Nurse Practitioner. The University of Arizona Cancer Center. David S. Ettinger, MD. Alex Grass Professor of Oncology. Sidney Kimmel Comprehensive Cancer Center. . at . Johns Hopkins. Disclosure of Conflicts of Interest. David S. Ettinger, MD, discloses that he has served as an advisor/consultant for Gilead, Roche/Genentech, Boehringer Ingelheim, Biodesix, Lilly, and Helsinn Therapeutics.. N Dr. Marinella is Assistant Clinical Professor of Internal Medicine,Wright State University School of Medicine, Dayton, OH, and a Hospi-talist, Miami Valley Hospital, Dayton. January 2000 Clinical Re Starter: answer these questions with reference to the reading you have been doing.. Summarise what . Lakoff. (1975) says about the characteristics of female talk?. Who is Otto Jespersen (1922) and how did he conceptualise gender differences in language?. Program Goals. The Importance of Controlling Nausea and Vomiting in the Setting of Chemotherapy. CINV: Consequences. Emetogenicity of IV Chemotherapy. Emetogenicity of Oral Chemotherapy. Types of CINV. Gender Stereotypes. Gender. – social interpretation of what it means to be a man or woman. Gender Stereotypes. —beliefs about how men and women differ or are supposed to differ, in contrast to what the actual differences are. . You . Peter Argenta, MD. Definition. The conditions that result when nerves that carry messages to and from the brain and spinal cord from and to the rest of the body are damaged or diseased.. What does it mean for patients?. Head, Palliative Care Research. Division of Cancer Prevention. NCI: Programmatic Overview of CIPN Portfolio. . March. , 2017. Objectives. Provide an overview of the NCI Community Oncology Research Program (NCORP). . Dr.Thabat. J. Al-. Maiahy. MBChB,DOG,CABOG. Radiotherapy. EXTERNAL RADIATION THERAPY. Indicated when an area to be irradiated is large, . e.g. cx cancer . The basic tent of radiation therapy is to maximize the tumor damage while minimizing the . Jessica Latchman APRN, AGACNP-BC AOCNP, ACHPN. Ann Guastella, APRN, AOCN, ACHPN. December 13, 2022. INTRODUCTION . Chemotherapy induced peripheral Neuropathy is common problem facing cancer patients . Lynn Howie, MD, Medical Officer, DOP1. Supportive Care is Crucial for . Cancer Treatment. Antiemetics. Growth factors. Bone health agents. Agents to reduce mucositis. Anti-diarrheals. Supportive care therapies reduce symptoms and side effects allowing for improved delivery of chemotherapy agents, many of which are given with curative intent . March 23, 2017. Jennifer Gewandter, PhD, MPH. Presentation objectives. Outline the design challenges and issues to consider when designing a CIPN study during chemotherapy. Summarize how published RCTs have addressed these design challenges. over 55 years of neuropathic toxicity: . if not now, when do we take . aaacttion. . Joanna M . Brell. , MD. Clinical Associate Professor of medicine. Case Western Reserve University. Associate Director Cancer Center for clinical research. n. ges in Clinical . T. rials for CIPN. Michael P. McDermott, Ph.D.. University of Rochester Medical Center. Measurement of outcome. Strategies for statistical analysis. Defining the study population.
Download Document
Here is the link to download the presentation.
"Gender differences in pre-clinical models of Chemotherapy Induced Neuropathy"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents